recurrent platinum-resistant epithelial ovarian cancer (EOC): Preliminary results of a randomized, multicenter phase II study. J Clin Oncol 25:276s, 2007 (suppl 18S; abstr 5508) 18. Tarhini AA, Christensen S, Frankel P, et al: Phase II study of aflibercept (VEGF trap) in recurrent inoperable stage III or stage IV melanoma of cutaneous or ocular origin. J Clin Oncol 27:468s, 2009 (suppl 15S; abstr 9028) 19. Hanna NH, von Pawel J, Reck M, et al: Carboplatin/paclitaxel with/without sorafenib in chemonaive patients with stage IIIB-IV non-small-cell lung cancer: Interim analysis results from a randomized phase III trial (ESCAPE). J Thorac Oncol 3:S268, 2008 (suppl) 20. Kim ES, Serur A, Huang J, et al: Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma. Proc Natl Acad Sci U S A 99:11399-11404, 2002 21. Dowlati A, Gray R, Sandler AB, et al: Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab: An Eastern Cooperative Oncology Group Study. Clin Cancer Res 14:14071412, 2008
No takes yet. Share an insight, caveat, or question.
Ralph M. Meyer (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: